You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Intravascular Cardiac Assist System for Decompression and Recovery
SBC: ABIOMED, INC. Topic: NHLBIDESCRIPTION (provided by applicant): The objective of this proposal is to develop a less invasive long-term copulsation device to treat patients in late Class III and early Class IV stages of heart failure (HF). Chronic congestive heart failure is the largest unsolved problem in cardiac care today. There are over 5.5 million people in the United States with this diagnosis and the number of patient ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
A Novel Polymeric Percutaneous Heart Valve Prosthesis
SBC: ABIOMED, INC. Topic: NHLBIDESCRIPTION (provided by applicant): The objective of this SBIR program is the modification of a polymeric trileaflet heart valve to a valve prosthesis that can be delivered percutaneously as a transcatheter aortic valve replacement. Key innovations include improved durability and hemodynamic properties, lower manufacturing costs, and simplified delivery over existing transcatheter bioprosthetic v ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Minimally Invasive Pediatric VAD for Treatment of Acute Heart Failure
SBC: ABIOMED, INC. Topic: NHLBIDESCRIPTION (provided by applicant): The overall objective of this proposed program is the commercialization of the Pediatric Impella system, a minimally invasive ventricular assist device (VAD) for treatment of acute heart failure in pediatric patients. The device will be a less traumatic alternative to extracorporeal membrane oxygenation (ECMO), the current standard of care for these patients. T ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Reducing Methadone's Arrhythmic potential
SBC: ACADEMIC PHARMACEUTICALS Topic: NHLBIDESCRIPTION (provided by applicant): Methadone is an important long-term maintenance therapy for drug addiction and currently is frequently used for analgesia. However, methadone prolongs the QT interval on the electrocardiogram and this increases risk for life threatening arrhythmias and has led to the FDA's placing a black box warning on methadone's label. Initial studies in our laboratory hav ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Novel Targeted Therapy for Breast Cancer
SBC: A&G PHARMACEUTICAL, INC. Topic: NCIDESCRIPTION (provided by applicant): Breast cancer remains one of the top three cancers to affect and cause mortality in women. Major shortcomings with current treatment are the high level of side effects induced in patients and insufficient efficacy, particularly for patients with metastatic disease. Targeted cancer therapy is designed to treat only the cancer cells and minimize damage to healthy ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
A COMPANION DIAGNOSTIC FOR PROGNOSIS OF KIDNEY CANCER
SBC: 20 20 Genesystems Inc Topic: NCIThis contract was awarded by the National Cancer Institute's Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) Program under the funding opportunity "Contract Topic: 277 Companion Diagnostics: Predictive and Prognostic Tests Enabling Personalized Medicine in Cancer Therapy."
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
SBC: 20 20 Genesystems Inc Topic: NCIDESCRIPTION (provided by applicant): The promise of personalized medicine relies on the development of diagnostic tests to categorize patients within small cohorts who will benefit from specific treatments. 20/20 GeneSystems, Inc. (20/20) is a small business concern focused on the development of diagnostics for personalized medicine. Towards this end, 20/20 has developed, with the support of the N ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
System for Increasing Patient Access to Eye Exams for Diabetic Retinopathy
SBC: AEON IMAGING LLC Topic: NEIDESCRIPTION (provided by applicant): The overall goal of the proposed SBIR program is to implement and evaluate a low cost retinal camera, the Laser Scanning Digital Camera (LSDC), in a system for diabetic retinopathy (DR) screening. Untreated DR has reached epidemic levels in underserved populations worldwide. As the LSDC has already demonstrated its readiness for DR screening in preliminary stud ...
SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
Compact Chemical Sensor for Measurement of Internal Dose of Environmental Agents
SBC: AGILTRON, INC. Topic: NIEHSDESCRIPTION (provided by applicant): Detection of exposure to environmental agents by measurement of internal dose of such agents or their metabolites, chemical or biological, requires rapid assessment and identification of exposure to both known and unknown threats. Fast detection and identification of exposure to such threats can provide prompt warning of the extent and severity of the exposure ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
TB Diagnostics at the Point of Care
SBC: AKONNI BIOSYSTEMS INC Topic: NIBIBDESCRIPTION (provided by applicant): Of all diseases, Tuberculosis (TB) represents one of, if not, the greatest health disparity between whites and minorities [1]. To be specific, for every TB-infected white person in the United States, there are an estimated 9 African-Americans, 8 Latinos, 6 Native Americans, 23 Asians, and 21 Native Hawaiian/Pacific Islanders with this disease [2]. Compounded wi ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health